SPARC

Sun Pharma, SPARC sign licence agreement for sale of seizure drug for injection in US

Mumbai-based Sun Pharma, including its subsidiaries, and Sun Pharma Advanced Research Company (SPARC) on Wednesday announced the signing of a licensing agreement for commercialisation of benzyl alcohol and propylene glycol-free phenobarbital sodium powder for injection in the US.

Business

SPARC shares jumps over 6% on BSE after it withdraws patent infringement complaint

SPARC will also inform the USFDA of the dismissal of the complaint to vacate the 30-month stay, the filing added.

SPARC

Sun Pharma, SPARC sign licence agreement for sale of seizure drug for injection in US

SPARC shares jumps over 6% on BSE after it withdraws patent infringement complaint

Today's Top Stories

‘We the Leaders’: After breaking with BJP, Annamalai launches own party in Tamil Nadu

5 things Russian Prez Vladimir Putin said to defend India, PM Modi at St Petersburg forum

Ramalinga Reddy resigns from Karnataka Cabinet days after oath, says ‘I’m still in Congress’

Anthropic reveals 80% of its code is now written by Claude and says the world needs a plan to hit the brakes

Son of a Chinese cleaner and a security guard, he crossed the Pacific, sold pancakes on LA streets, and now plans to run for mayor